CD57 Expression and Cytokine Production by T Cells in Lesional and Unaffected Skin from Patients with Psoriasis
dc.contributor | Sistema FMUSP-HC: Faculdade de Medicina da Universidade de São Paulo (FMUSP) e Hospital das Clínicas da FMUSP | |
dc.contributor.author | BATISTA, Mariana D. | |
dc.contributor.author | TINCATI, Camilla | |
dc.contributor.author | MILUSH, Jeffrey M. | |
dc.contributor.author | HO, Emily L. | |
dc.contributor.author | NDHLOVU, Lishomwa C. | |
dc.contributor.author | YORK, Vanessa A. | |
dc.contributor.author | KALLAS, Esper G. | |
dc.contributor.author | KALIL, Jorge | |
dc.contributor.author | KEATING, Sheila M. | |
dc.contributor.author | NORRIS, Philip J. | |
dc.contributor.author | CHANG, David | |
dc.contributor.author | UNEMORI, Patrick | |
dc.contributor.author | LESLIE, Kieron S. | |
dc.contributor.author | MAURER, Toby | |
dc.contributor.author | LIAO, Wilson | |
dc.contributor.author | NIXON, Douglas F. | |
dc.date.accessioned | 2013-09-23T16:36:07Z | |
dc.date.available | 2013-09-23T16:36:07Z | |
dc.date.issued | 2013 | |
dc.description.abstract | Background: The immunopathogenic mechanisms leading to psoriasis remain unresolved. CD57 is a marker of replicative inability and immunosenescence on CD8+ T cells and the proportion of CD57 expressing CD8+ T cells is increased in a number of inflammatory conditions. Methodology: We examined the expression of CD57 on T cells in the skin of patients affected with psoriasis, comparing lesional and unaffected skin. We also assessed functionality of the T cells by evaluating the secretion of several inflammatory cytokines (IL-17A, IFN-gamma, IL-2, IL-33, TNF-alpha, IL-21, IL-22, and IL-27), from cell-sorted purified CD4+ and CD8+ T cells isolated from lesional and unaffected skin biopsies of psoriasis patients. Principal Findings: We observed that the frequency of CD57+CD4+ and CD57+CD8+ T cells was significantly higher in unaffected skin of psoriasis patients compared to lesional skin. Sorted CD4+ T cells from psoriatic lesional skin produced higher levels of IL-17A, IL-22, and IFN-gamma compared to unaffected skin, while sorted CD8+ T cells from lesional skin produced higher levels of IL-17, IL-22, IFN-gamma, TNF-alpha, and IL-2 compared to unaffected skin. Conclusions/Significance: These findings suggest that T cells in unaffected skin from psoriasis patients exhibit a phenotype compatible with replicative inability. As they have a lower replicative capacity, CD57+ T cells are less frequent in lesional tissue due to the high cellular turnover. | |
dc.description.index | MEDLINE | |
dc.description.sponsorship | National Institutes of Health (NIH) [AI64520, 5T32HL007185] | |
dc.description.sponsorship | Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP) [04/15856-9, 2010/05845-0] | |
dc.description.sponsorship | Peter and Shelagh Godsoe Family Foundation | |
dc.description.sponsorship | UCSF REAC [37710/521717] | |
dc.description.sponsorship | American Academy of Neurology Clinical Research Training Fellowship | |
dc.description.sponsorship | National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIH-NIAMS) [5K08AR057763] | |
dc.description.sponsorship | International AIDS Society | |
dc.description.sponsorship | U.S. National Institutes of Health (NIH) | |
dc.description.sponsorship | UW Institute of Translational Health Sciences | |
dc.identifier.citation | PLOS ONE, v.8, n.2, article ID e52144, 6p, 2013 | |
dc.identifier.doi | 10.1371/journal.pone.0052144 | |
dc.identifier.issn | 1932-6203 | |
dc.identifier.uri | https://observatorio.fm.usp.br/handle/OPI/1763 | |
dc.language.iso | eng | |
dc.publisher | PUBLIC LIBRARY SCIENCE | |
dc.relation.ispartof | Plos One | |
dc.rights | openAccess | |
dc.rights.holder | Copyright PUBLIC LIBRARY SCIENCE | |
dc.subject.other | human keratinocytes | |
dc.subject.other | atopic-dermatitis | |
dc.subject.other | gene-expression | |
dc.subject.other | il-22 | |
dc.subject.other | differentiation | |
dc.subject.other | lymphocytes | |
dc.subject.other | immunopathogenesis | |
dc.subject.other | activation | |
dc.subject.other | immunity | |
dc.subject.other | subset | |
dc.subject.wos | Multidisciplinary Sciences | |
dc.title | CD57 Expression and Cytokine Production by T Cells in Lesional and Unaffected Skin from Patients with Psoriasis | |
dc.type | article | |
dc.type.category | original article | |
dc.type.version | publishedVersion | |
dspace.entity.type | Publication | |
hcfmusp.affiliation.country | Estados Unidos | |
hcfmusp.affiliation.countryiso | us | |
hcfmusp.author.external | TINCATI, Camilla:Univ Calif San Francisco, Dept Med, Div Expt Med, San Francisco, CA 94143 USA | |
hcfmusp.author.external | MILUSH, Jeffrey M.:Univ Calif San Francisco, Dept Med, Div Expt Med, San Francisco, CA 94143 USA | |
hcfmusp.author.external | HO, Emily L.:Univ Calif San Francisco, Dept Med, Div Expt Med, San Francisco, CA 94143 USA | |
hcfmusp.author.external | NDHLOVU, Lishomwa C.:Univ Calif San Francisco, Dept Med, Div Expt Med, San Francisco, CA 94143 USA | |
hcfmusp.author.external | YORK, Vanessa A.:Univ Calif San Francisco, Dept Med, Div Expt Med, San Francisco, CA 94143 USA | |
hcfmusp.author.external | KEATING, Sheila M.:Blood Syst Res Inst, San Francisco, CA USA; Univ Calif San Francisco, Dept Lab Med, San Francisco, CA USA | |
hcfmusp.author.external | NORRIS, Philip J.:Blood Syst Res Inst, San Francisco, CA USA; Univ Calif San Francisco, Dept Lab Med, San Francisco, CA USA; Univ Calif San Francisco, Dept Med, San Francisco, CA USA | |
hcfmusp.author.external | CHANG, David:Calif Pacific Med Ctr, San Francisco, CA USA | |
hcfmusp.author.external | UNEMORI, Patrick:Univ Calif San Francisco, Dept Dermatol, San Francisco, CA 94143 USA | |
hcfmusp.author.external | LESLIE, Kieron S.:Univ Calif San Francisco, Dept Dermatol, San Francisco, CA 94143 USA | |
hcfmusp.author.external | MAURER, Toby:Univ Calif San Francisco, Dept Dermatol, San Francisco, CA 94143 USA | |
hcfmusp.author.external | LIAO, Wilson:Univ Calif San Francisco, Dept Dermatol, San Francisco, CA 94143 USA | |
hcfmusp.author.external | NIXON, Douglas F.:Univ Calif San Francisco, Dept Med, Div Expt Med, San Francisco, CA 94143 USA | |
hcfmusp.citation.scopus | 9 | |
hcfmusp.contributor.author-fmusphc | MARIANA DIAS BATISTA | |
hcfmusp.contributor.author-fmusphc | ESPER GEORGES KALLAS | |
hcfmusp.contributor.author-fmusphc | JORGE ELIAS KALIL FILHO | |
hcfmusp.description.articlenumber | e52144 | |
hcfmusp.description.issue | 2 | |
hcfmusp.description.volume | 8 | |
hcfmusp.origem | WOS | |
hcfmusp.origem.pubmed | 23468834 | |
hcfmusp.origem.scopus | 2-s2.0-84874533147 | |
hcfmusp.origem.wos | WOS:000315524900002 | |
hcfmusp.publisher.city | SAN FRANCISCO | |
hcfmusp.publisher.country | USA | |
hcfmusp.relation.reference | Arai K, 1998, CLIN EXP IMMUNOL, V111, P345 | |
hcfmusp.relation.reference | Boniface K, 2005, J IMMUNOL, V174, P3695 | |
hcfmusp.relation.reference | Brenchley JM, 2003, BLOOD, V101, P2711, DOI 10.1182/blood-2002-07-2103 | |
hcfmusp.relation.reference | Cameron AL, 2002, ARCH DERMATOL RES, V294, P363, DOI 10.1007/s00403-002-0349-4 | |
hcfmusp.relation.reference | Caruso R, 2009, NAT MED, V15, P1013, DOI 10.1038/nm.1995 | |
hcfmusp.relation.reference | Chattopadhyay PK, 2009, J LEUKOCYTE BIOL, V85, P88, DOI 10.1189/jlb.0208107 | |
hcfmusp.relation.reference | Clark RA, 2010, J INVEST DERMATOL, V130, P362, DOI 10.1038/jid.2009.247 | |
hcfmusp.relation.reference | Clark RA, 2011, J INVEST DERMATOL, V131, P283, DOI 10.1038/jid.2010.374 | |
hcfmusp.relation.reference | Di Cesare A, 2009, J INVEST DERMATOL, V129, P1339, DOI 10.1038/jid.2009.59 | |
hcfmusp.relation.reference | Evans TG, 1999, AIDS, V13, P1139, DOI 10.1097/00002030-199906180-00019 | |
hcfmusp.relation.reference | Focosi D, 2010, J LEUKOCYTE BIOL, V87, P107, DOI 10.1189/jlb.0809566 | |
hcfmusp.relation.reference | Gudjonsson JE, 2009, J INVEST DERMATOL, V129, P2795, DOI 10.1038/jid.2009.173 | |
hcfmusp.relation.reference | Iking-Konert C, 2009, CLIN EXP RHEUMATOL, V27, pS19 | |
hcfmusp.relation.reference | Le Priol Y, 2006, J IMMUNOL, V177, P5145 | |
hcfmusp.relation.reference | Liang SC, 2006, J EXP MED, V203, P2271, DOI 10.1084/jem.20061308 | |
hcfmusp.relation.reference | Lowes MA, 2008, J INVEST DERMATOL, V128, P1207, DOI 10.1038/sj.jid.5701213 | |
hcfmusp.relation.reference | Mak R K H, 2009, Actas Dermosifiliogr, V100 Suppl 2, P2 | |
hcfmusp.relation.reference | Nestle FO, 2009, NEW ENGL J MED, V361, P496, DOI 10.1056/NEJMra0804595 | |
hcfmusp.relation.reference | Nograles KE, 2009, J ALLERGY CLIN IMMUN, V123, P1244, DOI 10.1016/j.jaci.2009.03.041 | |
hcfmusp.relation.reference | Nograles KE, 2008, BRIT J DERMATOL, V159, P1092, DOI 10.1111/j.1365-2133.2008.08769.x | |
hcfmusp.relation.reference | Ortega C, 2009, J LEUKOCYTE BIOL, V86, P435, DOI [10.1189/JLB.0109046, 10.1189/jlb.0109046] | |
hcfmusp.relation.reference | Palmer BE, 2005, J IMMUNOL, V175, P8415 | |
hcfmusp.relation.reference | Plant D, 2006, EXP DERMATOL, V15, P900, DOI 10.1111/j.1600-0625.2006.00486.x | |
hcfmusp.relation.reference | Res PCM, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014108 | |
hcfmusp.relation.reference | Sabat R, 2007, EXP DERMATOL, V16, P779, DOI 10.1111/j.1600-0625.2007.00629.x | |
hcfmusp.relation.reference | Shibata S, J INVEST DERMATOL, V130, P1034 | |
hcfmusp.relation.reference | Simpson RJ, 2008, BRAIN BEHAV IMMUN, V22, P544, DOI 10.1016/j.bbi.2007.11.002 | |
hcfmusp.relation.reference | Stritesky GL, 2008, J IMMUNOL, V181, P5948 | |
hcfmusp.relation.reference | Suarez-Farinas M, 2011, J INVEST DERMATOL, V131, P391, DOI 10.1038/jid.2010.280 | |
hcfmusp.relation.reference | Suarez-Farinas M, 2011, J ALLERGY CLIN IMMUN, V127, P954, DOI 10.1016/j.jaci.2010.12.1124 | |
hcfmusp.relation.reference | Tarazona R, 2000, MECH AGEING DEV, V121, P77 | |
hcfmusp.relation.reference | Teunissen MBM, 1998, J INVEST DERMATOL, V111, P645, DOI 10.1046/j.1523-1747.1998.00347.x | |
hcfmusp.relation.reference | Theoharides TC, P NATL ACAD SCI US, V107, P4448 | |
hcfmusp.relation.reference | Wilson NJ, 2007, NAT IMMUNOL, V8, P950, DOI 10.1038/ni1497 | |
hcfmusp.relation.reference | Wolk K, 2006, EUR J IMMUNOL, V36, P1309, DOI 10.1002/eji.200535503 | |
hcfmusp.relation.reference | Zenewicz LA, 2011, INT IMMUNOL, V23, P159, DOI 10.1093/intimm/dxr001 | |
hcfmusp.relation.reference | Zheng Y, 2007, NATURE, V445, P648, DOI 10.1038/nature05505 | |
hcfmusp.remissive.sponsorship | FAPESP | |
hcfmusp.remissive.sponsorship | NIH | |
hcfmusp.scopus.lastupdate | 2024-04-12 | |
relation.isAuthorOfPublication | 5c421f40-70f5-4d6d-825f-d7f2355991db | |
relation.isAuthorOfPublication | 28071dc0-9dc3-4896-81cf-c90be6515b24 | |
relation.isAuthorOfPublication | 039713b4-cdee-430a-b5dd-77d7d751b09b | |
relation.isAuthorOfPublication.latestForDiscovery | 5c421f40-70f5-4d6d-825f-d7f2355991db |
Arquivos
Pacote Original
1 - 1 de 1
Carregando...
- Nome:
- art_BATISTA_CD57_Expression_and_Cytokine_Production_by_T_Cells_2013.PDF
- Tamanho:
- 371.02 KB
- Formato:
- Adobe Portable Document Format
- Descrição:
- publishedVersion (English)